Search Results - "SANAD II collaborators"

The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.

Authors: Marson, Anthony Burnside, Girvan Appleton, Richard et al.

Source: Lancet. 4/10/2021, Vol. 397 Issue 10282, p1363-1374. 12p.

Subjects: Partial epilepsy, Lamotrigine, Anticonvulsants, National Institute for Health Research (Great Britain), Seizures (Medicine), Cost effectiveness, Levetiracetam, Epilepsy, Oral drug administration, Treatment effectiveness, Randomized controlled trials, Statistical sampling

The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.

Authors: Marson, Anthony Burnside, Girvan Appleton, Richard et al.

Source: Lancet. 4/10/2021, Vol. 397 Issue 10282, p1375-1386. 12p.

Subjects: Valproic acid, Anticonvulsants, National Institute for Health Research (Great Britain), Cost effectiveness, Technology assessment, Epilepsy, Medical technology, Levetiracetam, Research, Research methodology, Medical cooperation, Evaluation research, Comparative studies, Randomized controlled trials